Nivolumab Immunotherapy Plus Hydrogen Inhalation for Treatment of KRAS-Mutant pulmonary sarcomatoid carcinoma: A case report

Background: Pulmonary sarcomatoid carcinoma (PSC) as a rare subtype of nonsmall cell lung cancer (NSCLC) is resistant to conventional chemotherapy and radiotherapy with poor prognosis. Nivolumab is...